VACCA, ALESSANDRA
 Distribuzione geografica
Continente #
EU - Europa 36.124
NA - Nord America 2.583
AS - Asia 309
AF - Africa 2
OC - Oceania 2
Totale 39.020
Nazione #
IT - Italia 35.406
US - Stati Uniti d'America 2.570
SE - Svezia 264
UA - Ucraina 245
CN - Cina 235
GB - Regno Unito 60
FI - Finlandia 58
DE - Germania 56
SG - Singapore 46
FR - Francia 18
CA - Canada 13
IN - India 8
VN - Vietnam 8
IR - Iran 7
RU - Federazione Russa 6
BE - Belgio 4
IE - Irlanda 2
NL - Olanda 2
NZ - Nuova Zelanda 2
CZ - Repubblica Ceca 1
ES - Italia 1
IL - Israele 1
IQ - Iraq 1
JP - Giappone 1
LU - Lussemburgo 1
MU - Mauritius 1
SD - Sudan 1
TR - Turchia 1
TW - Taiwan 1
Totale 39.020
Città #
Cagliari 34.839
Uta 461
Fairfield 351
Woodbridge 327
Chandler 218
Houston 185
Nyköping 185
Ann Arbor 156
Ashburn 155
Wilmington 147
Seattle 143
Jacksonville 134
Cambridge 130
Boardman 127
Dearborn 85
Nanjing 45
Boston 34
Shanghai 29
San Diego 24
Shenyang 21
Singapore 20
Beijing 18
Redwood City 16
Hebei 15
Helsinki 15
San Mateo 15
Milan 13
Guangzhou 12
Nanchang 12
Toronto 11
Auburn Hills 10
Falls Church 10
Jiaxing 10
London 10
Norwalk 10
Dong Ket 8
Verona 8
Changsha 7
Mountain View 7
Tianjin 7
Hefei 6
Orange 6
Augusta 5
Borås 5
Duncan 5
Jinan 5
Ardabil 4
Brussels 4
Chicago 4
Renton 4
Zhengzhou 4
Cepagatti 3
Detroit 3
Hangzhou 3
Indiana 3
Kilburn 3
Kunming 3
Sassari 3
Amsterdam 2
Dublin 2
Fellbach 2
Leawood 2
Los Angeles 2
Mumbai 2
New Bedfont 2
Ningbo 2
Nürnberg 2
Oakville 2
Paris 2
Phoenix 2
Rome 2
Shaoxing 2
Taizhou 2
Tehran 2
Washington 2
Wuhan 2
Xian 2
Baghdad 1
Bologna 1
Cellatica 1
Columbus 1
Costa Mesa 1
Dalian 1
Delhi 1
Forest City 1
Foshan 1
Fremont 1
Fuzhou 1
Hamilton 1
Harbin 1
Hastings 1
Heze 1
Hounslow 1
Islington 1
Jinhua 1
Leyton 1
Lissone 1
Luxembourg 1
Miami Beach 1
Monmouth Junction 1
Totale 38.164
Nome #
Patient Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA and OMERACT Study 2.422
Defective cerebral gamma-aminobutyric acid-A receptor density in patients with systemic lupus erythematosus and central nervous system involvement. An observational study 2.217
Prognostic impact of coronary microcirculation abnormalities in systemic sclerosis: a prospective study to evaluate the role of non-invasive tests 2.001
Susceptibility to ankylosing spondylitis but not disease outcome is influenced by the level of HLA-B27 expression, which shows moderate variability over time 1.809
Rituximab treatment for 'rhupus syndrome': clinical and power-Doppler ultrasonographic monitoring of response. A longitudinal pilot study 1.664
Does subclinical atherosclerosis really exist in systemic sclerosis? Comment on the article by Turiel et al. 1.530
Genetics of seronegative spondyloarthritis, susceptibility and aetiopathogenesis: A single centre experience 1.330
The growing role of cardiac magnetic resonance imagin in assessment and follow-up of pulmonary arterial hypertension associated with systemic sclerosis 1.156
Vitamin D levels and potential impact in systemic sclerosis 1.012
Patient Assessments of Skin, Joint, and Nail Disease Activity in Psoriatic Arthritis Reply 999
Post-Streptococcal Reactive Arthritis Associated With Group G Streptococcal Pharyngitis 940
Multiple Septic Bursitis and Spontaneous Achilles Tendon Tear in Systemic Lupus Erythematosus 904
Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry 880
Prediction of Pulmonary Hypertension Related to Systemic Sclerosis by an Index Based on Simple Clinical Observations 877
Hemarthrosis as acute presentation of acquired hemophilia in a patient with systemic lupus erythematosus: successful treatment and long-lasting remission 876
Liver involvement in systemic lupus erythematosus: incidence, clinical course and outcome of lupus hepatitis 809
HLA-B*2709 and lack of susceptibility to sacroiliitis: further support from the clinic 803
Coronary atherosclerosis using computed tomography coronary angiography in patients with systemic sclerosis: comment on the article by Mok et al 791
Expert Agreement on EULAR/EUSTAR Recommendations for the Management of Systemic Sclerosis 785
Associated Autoimmune Diseases in Systemic Sclerosis Define a Subset of Patients with Milder Disease: Results from 2 Large Cohorts of European Caucasian Patients 782
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database 761
Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study 756
Familial chilblain and late contractural arachnodactyly: A novel association? 752
Association of MICA alleles with psoriatic arthritis and its clinical forms. A multicenter Italian study 749
A functional polymorphism of the vasoactive intestinal peptide receptor 1 gene correlates with the presence of HLA-B*2705 in Sardinia 737
Functional impairment of systemic scleroderma patients with digital ulcerations: results from the DUO Registry. 734
Treatment of Systemic Sclerosis Complications: What to Use When First-Line Treatment Fails-A Consensus of Systemic Sclerosis Experts 734
Evaluation of cardiac functional abnormalities in systemic sclerosis by dobutamine stress echocardiography. A myocardial echostress scleroderma pattern 708
Genetics of psoriasis and psoriatic arthritis 705
Absence of epicardial coronary stenosis in patients with systemic sclerosis and severe impairment of coronary flow reserve 639
The interplay between the geographic distribution of HLA-B27 alleles and their role in infectious and autoimmune diseases: A unifying hypothesis 634
null 622
Prevalence of Pulmonary Hypertension in Systemic Sclerosis in European Caucasians and Metaanalysis of 5 Studies 620
Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of disease 616
Vitamin D Deficiency and Insufficiency in 2 Independent Cohorts of Patients with Systemic Sclerosis 604
Primary antiphospholipid syndrome with mesenteric venous thrombosis presenting with intestinal infarction: a case description 600
Detection of early impairment of coronary flow reserve in patients with systemic sclerosis 597
Vitamin D Deficiency in a Cohort of Patients with Systemic Scleroderma from the South of Spain Reply 566
Bleomicin induced scleroderma: report of a case with a chronic course rather than the typical acute/subacute self-limiting form 546
Two distinctive HLA haplotypes harbor the B27 alleles negatively or positively associated with ankylosing spondylitis in Sardinia : Implications for disease pathogensis 527
Right atrial thrombosis in systemic lupus erythematosus 457
[The role of HLA-B27 molecules in the pathogenesis of ankylosing spondylitis]. FT Il ruolo delle molecole HLA-B27 nella patogenesi della spondilite anchilosante. 393
MICA gene triplet repeat polymorphism in patients with HLA-B27 positive and negative ankylosing spondylitis from sardinia 319
Effect of a single IV administration of L-propionylcarnitine on myocardial microcirculation assessed by coronary flow velocity reserve measurement in patients with systemic sclerosis: A pilot study 153
Totale 39.116
Categoria #
all - tutte 51.907
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.907


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.495 0 0 0 180 3.743 2.518 1.113 255 174 131 136 245
2020/202110.686 318 308 416 3.237 2.607 1.104 1.085 544 97 242 293 435
2021/20221.892 134 147 88 113 123 208 211 84 197 90 129 368
2022/20232.494 344 272 225 184 257 245 138 303 154 117 126 129
2023/20242.976 124 125 127 229 336 499 435 208 131 236 283 243
2024/20251.814 371 642 632 169 0 0 0 0 0 0 0 0
Totale 39.116